The FY21 RCRP program announcements and General Application Instructions for the FY21 Department of Defense Rare Cancers Research Program to support research of exceptional scientific merit in the area of rare cancers research the following award mechanisms are posted on the Grants.gov website.
The Melanoma Research Foundation has issued Request for Proposals for the 2021 Career Development Awards.
The FY21 Defense Appropriations Act provides funding to the Department of Defense Kidney Cancer Research Program to support research of exceptional scientific merit in the area of kidney cancer.
The FY21 Defense Appropriations Act provides funding to the Department of Defense Rare Cancers Research Program to support research of exceptional scientific merit in the area of rare cancers research.
The FY21 Defense Appropriations Act provides funding to the Department of Defense Prostate Cancer Research Program to support innovative, high-impact prostate cancer research.
The FY21 Defense Appropriations Act provides funding to the Department of Defense Breast Cancer Research Program to support innovative, high-impact research with clinical relevance that will accelerate progress to end breast cancer for service members, veterans, and the general public.
FY21 Ovarian Cancer Research Program Program Announcements and General Application Instructions for the Omics Consortium Award are posted on the Grants.gov website.
The FY21 Defense Appropriations Act is anticipated to provide funding for the Department of Defense Melanoma Research Program to support innovative, high-impact melanoma research.
The FY21 Defense Appropriations Act is anticipated to provide funding to the Department of Defense Kidney Cancer Research Program to support kidney cancer research. The KCRP is providing the information in this pre-announcement to allow investigators time to plan and develop ideas for submission to the anticipated FY21 funding opportunities. The FY21 KCRP program announcements... […]
The FY21 Defense Appropriations Act is anticipated to provide funding to the Department of Defense Prostate Cancer Research Program to support innovative, high-impact prostate cancer research.
